Efficacy and safety of neoadjuvant double anti-Her2 blockade combined with anthracycline-free chemotherapy in locally advanced breast cancer

被引：0
|
作者：
Rodriguez Garces, Maria Yeray
Garcia Samblas, Victoria
Morales Pancorbo, David
Bayo Calero, Juan Lucas
机构：
[1] Hosp Juan Ramon Jimenez, Huelva, Spain
[2] Juan Ramon Jimenez Hosp, Huelva, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12612
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pathologic complete response (pCR) in locally advanced HER2+(HER2+) breast cancer (BC) treated with anthracycline-free neoadjuvant therapy
    Somlo, G.
    Waisman, J.
    Yuan, Y.
    Kruper, L.
    Frankel, P.
    Jones, V.
    Lusi, T.
    Schmolze, D.
    Yim, J.
    Hurria, A.
    Mortimer, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Real-world efficacy of dual HER2-blockade in combination with anthracyclinecontaining and anthracycline-free neoadjuvant treatment in early breast cancer (BC)
    de Castro, Beatriz Alonso
    Reboredo, Cristina
    Calvo, Lourdes
    Perez-Lopez, Maria-Eva
    Randulfe Rodriguez, Martin Igor Gomez
    Diaz, Sofia Silva
    Vazquez, Iria Parajo
    Novoa, Silvia Antolin
    CANCER RESEARCH, 2024, 84 (09)
  • [3] HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Ma, Fei
    Fan, Ying
    Luo, Yang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (03): : E187 - E192
  • [4] Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer
    Lin, Binwei
    Fan, Jinjia
    Liu, Fang
    Wen, Yixue
    Li, Jie
    Gao, Feng
    Zhang, Yu
    Feng, Gang
    Du, Xiaobo
    Chen, Wenzhi
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [5] Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer
    Lin, Binwei
    Fan, Jinjia
    Liu, Fang
    Wen, Yixue
    Li, Jie
    Gao, Feng
    Zhang, Yu
    Feng, Gang
    Du, Xiaobo
    Chen, Wenzhi
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [6] Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
    Bardakci, Murat
    Karakas, Hilal
    Bayram, Dogan
    Avci, Nilufer
    Kitapli, Sait
    Ozen, Mirac
    Aslan, Ferit
    Koseoglu, Caglar
    Kadioglu, Ahmet
    Onur, Ilknur D.
    Sakalar, Teoman
    Buyuksimsek, Mahmut
    Alkan, Ali
    Ergun, Yakup
    Kaya, Ali O.
    Bilgin, Burak
    Yalcin, Bulent
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Anthracycline-free therapy for HER2-amplified breast cancer
    Gennari, Alessandra
    Del Mastro, Lucia
    LANCET ONCOLOGY, 2013, 14 (11): : 1037 - 1038
  • [8] Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis
    Debiasi, Marcio
    Polanczyk, Carisi A.
    Ziegelmann, Patricia
    Barrios, Carlos
    Cao, Hongyuan
    Dignam, James J.
    Goss, Paul
    Bychkovsky, Brittany
    Finkelstein, Dianne M.
    Guindalini, Rodrigo S.
    Filho, Paulo
    Albuquerque, Caroline
    Reinert, Tomas
    de Azambuja, Evandro
    Olopade, Olufunmilayo
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [9] Pertuzumab and Trastuzumab in Combination with an Anthracycline-containing or an Anthracycline-free Standard Chemotherapy in the Neoadjuvant Treatment of HER2-positive Breast Cancer (TRYPHAENA)
    Schneeweiss, A.
    Chia, S.
    Hickish, T.
    Harvey, V.
    Hegg, R.
    Tausch, C.
    Seo, J. H.
    Tsai, Y. F.
    McNally, V.
    Cortes, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S96 - S96
  • [10] Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients
    Rurina Watanuki
    Tetsu Hayashida
    Yuko Kawai
    Masayuki Kikuchi
    Ayako Nakashoji
    Takamichi Yokoe
    Tomoka Toyota
    Tomoko Seki
    Maiko Takahashi
    Yuko Kitagawa
    International Journal of Clinical Oncology, 2019, 24 : 807 - 814
12345